Business Context and Reporting Period
This Form 6-K filing by Alcon, Inc. covers the month of May 2008 and reports on the outcomes of the Annual General Meeting of Shareholders held on May 6, 2008, in Zug, Switzerland, as well as subsequent Board of Directors actions.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the current period. It references the approval of the 2007 Annual Report and Accounts but does not detail the numerical results within this document.
- Dividend: A dividend of CHF 2.63 per share was approved, payable on May 22, 2008, to shareholders of record on May 12, 2008.
- Share Capital Reduction: Cancellation of 7,657,400 repurchased shares at CHF 0.20 par value, reducing share capital from CHF 62,347,145.60 to CHF 60,815,665.60.
Material Changes and Corporate Actions
Significant corporate governance and capital structure changes were approved:
- Board Elections: Paul Bulcke and James Singh were elected as new directors. Thomas G. Plaskett, Paul Polman, and Cary R. Rayment were re-elected. The election of James Singh and Dr. Daniel Vasella is subject to the closing of the sale of at least 74 million Alcon shares by Nestlé S.A. to Novartis AG.
- Leadership Roles: Cary Rayment was re-elected as Chairman and Francisco Castañer as Vice-Chairman.
- Auditors: KPMG Klynveld Peat Marwick Goerdeler SA was re-elected as Group and Parent Company Auditors. OBT AG was elected as special auditors.
- Director Compensation: Annual cash retainers of $85,000 (plus $15,000 for the Audit Committee Chairman) were approved for non-employee directors. Additionally, awards of 1,500 share-settled stock appreciation rights (SSARs) and 425 restricted share units (RSUs) were approved, with a three-year vesting period.
Outlook, Risks, and Contingencies
The filing notes that the share cancellation is expected to become effective in July or August 2008, subject to the fulfillment of certain formal Swiss law requirements. The election of two new board members is contingent upon the completion of the share sale transaction between Nestlé and Novartis.
Investor Verification Checklist
- Verify the record date (May 12, 2008) and payment date (May 22, 2008) for the CHF 2.63 dividend.
- Confirm the status of the Nestlé to Novartis share sale transaction to determine if the elections of James Singh and Dr. Daniel Vasella take effect.
- Monitor the effective date of the share capital reduction (expected July or August 2008).
- Review the full 2007 Annual Report and Accounts referenced in the filing for detailed financial performance metrics.